TNF and rheumatoid arthritis: For example, an observational cohort study with 2879 RA patients treated with tumor necrosis factor alpha inhibitor (TNFi) (etanercept/infliximab) in a British registry suggested that women were 40% significantly less likely to achieve DAS28-remission [27].